Lyra Therapeutics Inc (LYRA)

New Form 8-K - Lyra Therapeutics, Inc. Filed: 2025-06-27 AccNo: 0001193125-25-150301 Size: 685 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Safety Shot Inc (SHOT)

New Form 8-K - Safety Shot, Inc. Filed: 2025-06-27 AccNo: 0001641172-25-016825 Size: 3 MB Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 2.04: Triggering Events That Accelerate or Increase …

ProPhase Labs Inc. (PRPH)

New Form 8-K/A - ProPhase Labs, Inc. Filed: 2025-06-27 AccNo: 0001641172-25-016815 Size: 975 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: …

Helius Medical Technologies Inc (HSDT)

New Form 8-K - HELIUS MEDICAL TECHNOLOGIES, INC. Filed: 2025-06-27 AccNo: 0001558370-25-008942 Size: 206 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

Eastman Chemical Company (EMN)

New Form 8-K - EASTMAN CHEMICAL CO Filed: 2025-06-27 AccNo: 0000915389-25-000136 Size: 282 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits